Editorial: Botulinum intoxication – a case for systematic studies of patient recovery
by Michael Adler
The Botulinum J. (TBJ), Vol. 1, No. 2, 2008

Abstract: Since its approval in 1989 by the US FDA, Botulinum Neurotoxin (BoNT) has become the drug of choice for an increasing number of neurological and autonomic indications. Used in this controlled manner, BoNT has an exemplary record of safety and efficacy. Exposure to much higher doses of BoNT from contaminated food, penetrating wounds or aerosolised toxin leads to botulism. This editorial calls for systematic long-term clinical and psychological studies to be carried out not only to provide better care for the victims of natural BoNT outbreaks but also to improve our ability to deal with mass casualty situations.

Online publication date: Tue, 16-Jun-2009

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the The Botulinum J. (TBJ):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com